Radiation Oncology/Therapy: Page 226

Nucletron gets Japanese brachytherapy approval
By AuntMinnie.com staff writers
Brachytherapy firm Nucletron has received Shonin approval from the Japanese Ministry of Health, Labor, and Welfare to sell its microSelectron Digital brachytherapy afterloader in Japan.
February 20, 2012
Elekta gets FDA OK for ultrasound option
By AuntMinnie.com staff writers
Oncology firm Elekta has received 510(k) clearance from the U.S. Food and Drug Administration for an autoscan option that allows remote, automated ultrasound scanning with Elekta's Clarity soft-tissue visualization system.
February 20, 2012
Elekta gets FDA OK for Fraxion head frame
By AuntMinnie.com staff writers
Oncology firm Elekta has received clearance from the U.S. Food and Drug Administration for its Fraxion head frame.
February 16, 2012
Female cancer survivors show riskier behavior
By AuntMinnie.com staff writers
Female cancer survivors receiving screening mammography have "worse health behaviors" than women receiving mammography screening who never had cancer, according to a study published in the American Journal of Clinical Oncology.
February 16, 2012
Elekta to tout Mosaiq upgrades at HIMSS
By AuntMinnie.com staff writers
Oncology firm Elekta will demonstrate the most recent version of its Mosaiq oncology information system at next week's Healthcare Information and Management Systems Society (HIMSS) meeting in Las Vegas.
February 15, 2012
IsoRay loss widens in Q2
By AuntMinnie.com staff writers
Affected by declining volume in prostate brachytherapy procedures, medical isotope developer IsoRay Medical posted flat revenues and an increased loss in its fiscal 2012 second quarter.
February 15, 2012
Rad therapy may create breast cancer stem cells
By AuntMinnie.com staff writers
When a breast cancer patient has a radiation therapy treatment, half of any residual tumor cells are killed. However, radiation therapy intended to cure patients may transform the other 50% into treatment-resistant breast cancer stem cells, according to an article published online February 10 in Stem Cells.
February 15, 2012
CIVCO promotes Therme
By AuntMinnie.com staff writers
Ultrasound and radiotherapy products developer CIVCO Medical Solutions has promoted Robin Therme to senior vice president of sales and marketing for its Multi-Modality Imaging business group.
February 14, 2012
Post-op rad therapy unneeded for elderly lung cancer patients
By Cynthia E. Keen
Patients who have undergone surgery to resect stage III non-small cell lung cancer with N2 lymph node involvement may not need postoperative radiation therapy if they are older than 65, as the treatment doesn't help survival, according to an article published online February 13 in Cancer.
February 12, 2012
Choline-PET/CT changes prostate cancer treatment plans
By Wayne Forrest
Swiss researchers have found that PET/CT scans with the radiopharmaceutical choline can change treatment plans for certain patients with recurrent prostate cancer. Study results showed that choline-PET/CT significantly affected therapy management.
February 9, 2012
ASTRO issues guidelines for brain mets
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has issued evidence-based guidelines for radiotherapy and surgical management of cancer patients with newly diagnosed brain metastasis.
February 8, 2012
CIVCO shuffles management
By AuntMinnie.com staff writers
Ultrasound and radiotherapy products developer CIVCO Medical Solutions has promoted several executives within its radiation oncology sales and marketing organization.
February 8, 2012
Previous Page
Page 226 of 467
Next Page